Bamboos Health Care Holdings Limited (2293) released its Annual Report for the year ended 30 June 2025, recording consolidated revenue of HK$74.4 million, down 21.5% from the previous year. Profit attributable to shareholders stood at HK$17.5 million, representing a 43.3% decrease from HK$30.9 million in the prior year. The company’s net profit margin dropped from 32.6% to 23.6%.

Management attributed the subdued results partly to the decline in institutional and private healthcare staffing demand. Revenue from healthcare staffing solution services reached HK$61.7 million, the largest segment in total turnover. The company served approximately 32,000 registered healthcare personnel as of 30 June 2025, expanding its pool by 7.4% year-on-year.

Despite the challenging conditions, Bamboos adhered to its stable dividend policy. The board proposed a final dividend of HK1.50 cents per share for FY2025. Together with the interim dividend already paid, total dividends for the year amounted to HK4.00 cents per share.

Looking ahead, the group plans to continue strengthening its core healthcare staffing business and expand its “healtHUB” ecosystem, which integrates various healthcare services, including prevention, treatment, and rehabilitation. Additionally, the group remains active in prudent treasury management by diversifying part of its cash into stable assets such as acquisitions of shares in the SPDR Gold Trust. Management reiterated its cautious stance on maintaining sufficient liquidity and monitoring macroeconomic uncertainties.